Table of Contents Author Guidelines Submit a Manuscript
Infectious Diseases in Obstetrics and Gynecology
Volume 2006, Article ID 80383, 7 pages
http://dx.doi.org/10.1155/IDOG/2006/80383
Clinical Study

Knowledge and Awareness of Congenital Cytomegalovirus Among Women

1National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
2Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA
3National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
4Department of Pediatrics, Medical College of Virginia, Virginia Commonwealth University, Richmond, VA 23298, USA
5Developmental Cognitive Neuroscience Laboratory, Department of Communication Sciences and Disorders, Northwestern University, Evanston, IL 60208, USA
6Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA
7Department of Pediatrics, School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35213, USA
8Children's Hospital, Cleveland Clinic, Cleveland, OH 44104, USA
9Department of Pediatrics, School of Medicine, Emory University, Atlanta, GA 30322, USA

Received 2 August 2006; Accepted 13 September 2006

Copyright © 2006 Jiyeon Jeon et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M A Gaytant, E AP Steegers, B A Semmekrot, H MMW Merkus, and J MD Galama, “Congenital cytomegalovirus infection: review of the epidemiology and outcome,” Obstetrical and Gynecological Survey, vol. 57, no. 4, pp. 245–256, 2002. View at Publisher · View at Google Scholar
  2. J G Dobbins, J A Stewart, and G Demmler, “Surveillance of congenital cytomegalovirus disease, 1990-1991. Collaborating Registry Group,” Morbidity and Mortality Weekly Report. CDC Surveillance Summaries, vol. 41, no. 2, pp. 35–39, 1992. View at Google Scholar
  3. S B Boppana, K Fowler, W J Britt, S Stagno, and R F Pass, “Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus,” Pediatrics, vol. 104, no. 1, part 1, pp. 55–60, 1999. View at Publisher · View at Google Scholar
  4. K Fowler, S Stagno, R F Pass, W J Britt, T J Boll, and C A Alford, “The outcome of congenital cytomegalovirus infection in relation to maternal antibody status,” New England Journal of Medicine, vol. 326, no. 10, pp. 663–667, 1992. View at Google Scholar
  5. G Demmler, “Infectious Diseases Society of America and Centers for Disease Control: summary of a workshop on surveillance for congenital cytomegalovirus disease,” Reviews of Infectious Diseases, vol. 13, no. 2, pp. 315–329, 1991. View at Google Scholar
  6. S Stagno and R J Whitley, “Herpesvirus infections of pregnancy. Part II. Herpes simplex virus and varicella-zoster virus infections,” New England Journal of Medicine, vol. 313, no. 21, pp. 1327–1330, 1985. View at Google Scholar
  7. M J Cannon and K F Davis, “Washing our hands of the congenital cytomegalovirus disease epidemic,” BMC Public Health, vol. 5, p. 70, 2005. View at Publisher · View at Google Scholar
  8. S Stagno, R F Pass, G Cloud et al., “Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome,” Journal of the American Medical Association, vol. 256, no. 14, pp. 1904–1908, 1986. View at Publisher · View at Google Scholar
  9. S P Adler, J W Finney, A M Manganello, and A LM Best, “Prevention of child-to-mother transmission of cytomegalovirus by changing behaviors: a randomized controlled trial,” Pediatric Infectious Disease Journal, vol. 15, no. 3, pp. 240–246, 1996. View at Publisher · View at Google Scholar
  10. “ACOG practice bulletin. Perinatal viral and parasitic infections. Number 20, September 2000. (Replaces educational bulletin number 177, February 1993). American College of Obstetrics and Gynecologists,” International Journal of Gynaecology and Obstetrics, vol. 76, no. 1, pp. 95–107, 2002.
  11. R F Pass, A M August, M Dworsky, and D W Reynolds, “Cytomegalovirus infection in a day-care center,” New England Journal of Medicine, vol. 307, no. 8, pp. 477–479, 1982. View at Google Scholar
  12. R F Pass, C Hutto, R Ricks, and G A Cloud, “Increased rate of cytomegalovirus infection among parents of children attending day-care centers,” New England Journal of Medicine, vol. 314, no. 22, pp. 1414–1418, 1986. View at Google Scholar
  13. G Chang, L Wilkins-Haug, S Berman, and M A Goetz, “Brief intervention for alcohol use in pregnancy: a randomized trial,” Addiction, vol. 94, no. 10, pp. 1499–1508, 1999. View at Publisher · View at Google Scholar
  14. A O Carter, S B Gelmon, G A Wells, and A P Toepell, “The effectiveness of a prenatal education programme for the prevention of congenital toxoplasmosis,” Epidemiology and Infection, vol. 103, no. 3, pp. 539–545, 1989. View at Google Scholar
  15. Z S Pawlowski, M Gromadecka-Sutkiewicz, J Skommer et al., “Impact of health education on knowledge and prevention behavior for congenital toxoplasmosis: the experience in Poznan, Poland,” Health Education Research, vol. 16, no. 4, pp. 493–502, 2001. View at Publisher · View at Google Scholar
  16. G Chang, M A Goetz, L Wilkins-Haug, and S Berman, “A brief intervention for prenatal alcohol use. An in-depth look,” Journal of Substance Abuse Treatment, vol. 18, no. 4, pp. 365–369, 2000. View at Publisher · View at Google Scholar
  17. J R Hankin, “Fetal alcohol syndrome prevention research,” Alcohol Research and Health, vol. 26, no. 1, pp. 58–65, 2002. View at Google Scholar
  18. “Centers for Disease Control and Prevention (CDC). Spina bifida and anencephaly before and after folic acid mandate - United States, 1995-1996 and 1999-2000,” Morbidity and Mortality Weekly Report, vol. 53, no. 17, pp. 362–365, 2004.
  19. S P Adler, J W Finney, A M Manganello, and A M Best, “Prevention of child-to-mother transmission of cytomegalovirus among pregnant women,” Journal of Pediatrics, vol. 145, no. 4, pp. 485–491, 2004. View at Publisher · View at Google Scholar
  20. M G Revello and G Gerna, “Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant,” Clinical Microbiology Reviews, vol. 15, no. 4, pp. 680–715, 2002. View at Publisher · View at Google Scholar
  21. D B Jr Bailey, “Newborn Screening for Fragile X Syndrome,” Mental Retardation and Developmental Disabilities Research Reviews, vol. 10, no. 1, pp. 3–10, 2004. View at Publisher · View at Google Scholar
  22. G T Maine, T Lazzarotto, and M-P Landini, “New developments in the diagnosis of maternal and congenital CMV infection,” Expert Review of Molecular Diagnostics, vol. 1, no. 1, pp. 19–29, 2001. View at Publisher · View at Google Scholar
  23. G Nigro, S P Adler, and R La Torre, “Passive immunization during pregnancy for congenital cytomegalovirus infection,” New England Journal of Medicine, vol. 353, no. 13, pp. 1350–1362, 2005. View at Publisher · View at Google Scholar
  24. A M Arvin, P Fast, M Myers, S Plotkin, R Rabinovich, and National Vaccine Advisory Committee, “Vaccine development to prevent cytomegalovirus disease: report from the National Vaccine Advisory Committee,” Clinical Infectious Diseases, vol. 39, no. 2, pp. 233–239, 2004. View at Publisher · View at Google Scholar